INDV
Price
$24.98
Change
+$0.25 (+1.01%)
Updated
Sep 5 closing price
Capitalization
3.09B
47 days until earnings call
IPSEF
Price
$113.13
Change
+$9.63 (+9.30%)
Updated
Jun 9 closing price
Capitalization
11.56B
Interact to see
Advertisement

INDV vs IPSEF

Header iconINDV vs IPSEF Comparison
Open Charts INDV vs IPSEFBanner chart's image
Indivior
Price$24.98
Change+$0.25 (+1.01%)
Volume$3.44M
Capitalization3.09B
Ipsen S.A
Price$113.13
Change+$9.63 (+9.30%)
Volume$150
Capitalization11.56B
INDV vs IPSEF Comparison Chart in %
Loading...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INDV vs. IPSEF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDV is a Hold and IPSEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (INDV: $24.98 vs. IPSEF: $113.13)
Brand notoriety: INDV and IPSEF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INDV: 57% vs. IPSEF: 100%
Market capitalization -- INDV: $3.09B vs. IPSEF: $11.56B
INDV [@Pharmaceuticals: Generic] is valued at $3.09B. IPSEF’s [@Pharmaceuticals: Generic] market capitalization is $11.56B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDV’s FA Score shows that 0 FA rating(s) are green whileIPSEF’s FA Score has 2 green FA rating(s).

  • INDV’s FA Score: 0 green, 5 red.
  • IPSEF’s FA Score: 2 green, 3 red.
According to our system of comparison, IPSEF is a better buy in the long-term than INDV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDV’s TA Score shows that 2 TA indicator(s) are bullish.

  • INDV’s TA Score: 2 bullish, 3 bearish.

Price Growth

INDV (@Pharmaceuticals: Generic) experienced а +2.88% price change this week, while IPSEF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

INDV is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPSEF($11.6B) has a higher market cap than INDV($3.09B). INDV has higher P/E ratio than IPSEF: INDV (30.84) vs IPSEF (18.07). INDV YTD gains are higher at: 100.965 vs. IPSEF (-9.763). IPSEF has higher annual earnings (EBITDA): 1.3B vs. INDV (261M). IPSEF has more cash in the bank: 1.45B vs. INDV (510M). INDV has less debt than IPSEF: INDV (366M) vs IPSEF (869M). IPSEF has higher revenues than INDV: IPSEF (3.76B) vs INDV (1.17B).
INDVIPSEFINDV / IPSEF
Capitalization3.09B11.6B27%
EBITDA261M1.3B20%
Gain YTD100.965-9.763-1,034%
P/E Ratio30.8418.07171%
Revenue1.17B3.76B31%
Total Cash510M1.45B35%
Total Debt366M869M42%
FUNDAMENTALS RATINGS
INDV vs IPSEF: Fundamental Ratings
INDV
IPSEF
OUTLOOK RATING
1..100
8647
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
4735
SMR RATING
1..100
6291
PRICE GROWTH RATING
1..100
3559
P/E GROWTH RATING
1..100
10022
SEASONALITY SCORE
1..100
8510

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPSEF's Valuation (26) in the null industry is significantly better than the same rating for INDV (94). This means that IPSEF’s stock grew significantly faster than INDV’s over the last 12 months.

IPSEF's Profit vs Risk Rating (35) in the null industry is in the same range as INDV (47). This means that IPSEF’s stock grew similarly to INDV’s over the last 12 months.

INDV's SMR Rating (62) in the null industry is in the same range as IPSEF (91). This means that INDV’s stock grew similarly to IPSEF’s over the last 12 months.

INDV's Price Growth Rating (35) in the null industry is in the same range as IPSEF (59). This means that INDV’s stock grew similarly to IPSEF’s over the last 12 months.

IPSEF's P/E Growth Rating (22) in the null industry is significantly better than the same rating for INDV (100). This means that IPSEF’s stock grew significantly faster than INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDVIPSEF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
54%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
60%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
17%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
13%
Advances
ODDS (%)
Bullish Trend 1 day ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
72%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SNXFX14.03N/A
N/A
Schwab 1000 Index®
SEGIX41.60N/A
N/A
NAA Large Cap Value C
TIREX18.03N/A
N/A
Nuveen Real Estate Sec Sel R6
BIRCX22.42N/A
N/A
BlackRock Sustainable Adg Lg Cp Cr C
DRLIX8.69N/A
N/A
BNY Mellon Developed Markets RE Scs - I

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and CAIHF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and CAIHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+1.01%
CAIHF - INDV
27%
Poorly correlated
N/A
ASRT - INDV
26%
Poorly correlated
-1.19%
ALKS - INDV
25%
Poorly correlated
+3.53%
MKKGY - INDV
24%
Poorly correlated
+1.66%
HROW - INDV
24%
Poorly correlated
+2.18%
More

IPSEF and

Correlation & Price change

A.I.dvisor tells us that IPSEF and TEVJF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPSEF and TEVJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSEF
1D Price
Change %
IPSEF100%
N/A
TEVJF - IPSEF
24%
Poorly correlated
N/A
IPSEY - IPSEF
6%
Poorly correlated
+3.39%
JUSHF - IPSEF
6%
Poorly correlated
+6.59%
INDV - IPSEF
5%
Poorly correlated
+1.01%
INIS - IPSEF
2%
Poorly correlated
N/A
More